{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:38:04Z","timestamp":1786739884239,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>Gonadotropin-releasing hormone (GnRH) agonist trigger mimics the natural surge more closely with both luteinizing hormone (LH) and follicle-stimulating hormone surge. The present study attempts to find whether this apparent physiological advantage translates into the better pregnancy rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To compare the effect of GnRH agonist versus human chorionic gonadotropin (hCG) trigger on the clinical pregnancy rate (CPR) in infertile women undergoing intrauterine insemination (IUI) with oral ovulogens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>\n                      Retrospective analysis at a tertiary care\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      fertilization center.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      The records of 280 infertile women, who underwent IUI with oral ovulogens were analyzed. Women who received 0.2 mg triptorelin (GnRH agonist (GnRHa)) as trigger were categorised in Group A (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 129) and those who received 10,000 IU urinary hCG in Group B (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 151). The outcome in terms of CPR was studied.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>\n                      The quantitative variables were compared using the independent\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test\/Mann\u2013Whitney test. The qualitative variables were compared using the Chi-square test.\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05 was considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There was a trend toward better CPR in Group A (21\/129 \u2013 16.28%) than in Group B (16\/151 \u2013 10.60%), although the difference was not found to be statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2013 0.162).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>There was a trend toward better CPR with the use of GnRH agonist trigger in IUI cycles with oral ovulogens in comparison to hCG trigger, although the difference was not found to be statistically significant. Further randomized controlled trials are needed to confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_100_20","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T04:51:07Z","timestamp":1632804667000},"page":"267-272","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["To Compare the Effect of GnRH Agonist versus Human Chorionic Gonadotropin (HCG) Trigger on Clinical Pregnancy Rate in Intrauterine Insemination Cycle"],"prefix":"10.4103","volume":"14","author":[{"given":"Rashmi","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imlesh","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20240905","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/00016347309158325","article-title":"\u201cTriggering\u201d of ovulation after infusion of synthetic luteinizing hormone releasing factor (LRF)","volume":"52","author":"Nakano","year":"1973","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R2-8-20240905","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(84)92840-X","article-title":"Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins","volume":"2","author":"Porter","year":"1984","journal-title":"Lancet"},{"key":"R3-8-20240905","first-page":"165","article-title":"The introduction of LH surge and oocyte maturation by GnRH analog (buserelin) in women undergoing ovarian stimulation for in vitro fertilization","volume":"2","author":"Itskovitz","year":"1988","journal-title":"Gynecol Endocrinol"},{"key":"R4-8-20240905","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"key":"R5-8-20240905","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"Copenhagen GnRH Agonist Triggering Workshop Group. GnRH agonist for triggering of final oocyte maturation: Time for a change of practice?","volume":"17","author":"Humaidan","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R7-8-20240905","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1472-6483(10)61826-3","article-title":"Effect of FSH and its different isoforms on maturation of oocytes from pre-ovulatory follicles","volume":"5","author":"Yding Andersen","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"R8-8-20240905","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/281483a0","article-title":"FSH stimulates hyaluronic acid synthesis by oocyte-cumulus cell complexes from mouse preovulatory follicles","volume":"281","author":"Eppig","year":"1979","journal-title":"Nature"},{"key":"R9-8-20240905","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/molehr\/5.8.726","article-title":"FSH-induced resumption of meiosis in mouse oocytes: Effect of different isoforms","volume":"5","author":"Yding Andersen","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"R10-8-20240905","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1095\/biolreprod53.6.1302","article-title":"Regulation of rat granulosa cell plasminogen activator system: Influence of interleukin-1 beta and ovarian follicular development","volume":"53","author":"Karakji","year":"1995","journal-title":"Biol Reprod"},{"key":"R11-8-20240905","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1095\/biolreprod.104.038083","article-title":"Regulated expression of ADAMTS family members in follicles and cumulus oocyte complexes: Evidence for specific and redundant patterns during ovulation","volume":"72","author":"Richards","year":"2005","journal-title":"Biol Reprod"},{"key":"R12-8-20240905","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.fertnstert.2011.01.019","article-title":"Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: A randomized, double-blind, placebo-controlled trial","volume":"95","author":"Lamb","year":"2011","journal-title":"Fertil Steril"},{"key":"R13-8-20240905","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.rbmo.2016.08.009","article-title":"Adjuvant gonadotrophin-releasing hormone agonist trigger with human chorionic gonadotrophin to enhance ooplasmic maturity","volume":"33","author":"Pereira","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"R14-8-20240905","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10815-017-0979-2","article-title":"The benefits of dual and double ovulatory triggers in assisted reproduction","volume":"34","author":"Elias","year":"2017","journal-title":"J Assist Reprod Genet"},{"key":"R15-8-20240905","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of Gonadotrpin- releasing hormone agonist to trigger follicular maturation for in vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-8-20240905","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.rbmo.2015.12.007","article-title":"GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: A SWOT analysis","volume":"32","author":"Engmann","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"R17-8-20240905","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.fertnstert.2011.03.109","article-title":"Comparison of \u201ctriggers\u201d using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin","volume":"95","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"R18-8-20240905","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2010.09.009","article-title":"Efficacy of induced luteinizing hormone surge after \u201ctrigger\u201d with gonadotropin-releasing hormone agonist","volume":"95","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"R19-8-20240905","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.fertnstert.2015.01.035","article-title":"Major drawbacks and additional benefits of agonist trigger \u2013 Not ovarian hyperstimulation syndrome related","volume":"103","author":"Shapiro","year":"2015","journal-title":"Fertil Steril"},{"key":"R21-8-20240905","first-page":"13","article-title":"Endocrine and paracrine-autocrine regulation of the human corpus luteum during the mid-luteal phase","volume":"55","author":"Devoto","year":"2000","journal-title":"J Reprod Fertil"},{"key":"R22-8-20240905","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1016\/S1472-6483(10)61065-6","article-title":"The luteal phase after 3 decades of IVF: What do we know?","volume":"19","author":"Fatemi","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"R23-8-20240905","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2014.01.019","article-title":"Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and \u201cfreeze-all\u201d approach in GnRH antagonist protocol","volume":"101","author":"Fatemi","year":"2014","journal-title":"Fertil Steril"},{"key":"R24-8-20240905","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","article-title":"The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: A prospective randomized controlled study","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"R25-8-20240905","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.rbmo.2010.06.031","article-title":"LH (as HCG) and FSH surges for final oocyte maturation: Sometimes it takes two to tango?","volume":"21","author":"Kol","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"R26-8-20240905","doi-asserted-by":"crossref","first-page":"351","DOI":"10.29252\/ijrm.15.6.351","article-title":"Comparing the effect of gonadotropin-releasing hormone agonist and human chorionic gonadotropin on final oocytes for ovulation triggering among infertile women undergoing intrauterine insemination: An RCT","volume":"15","author":"Taheripanah","year":"2017","journal-title":"Int J Reprod Biomed"},{"key":"R27-8-20240905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2487067","article-title":"GnRH agonist versus hCG trigger in ovulation induction with intrauterine insemination: A randomized controlled trial","volume":"2019","author":"Le","year":"2019","journal-title":"Int J Endocrinol"},{"key":"R28-8-20240905","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/humrep\/deq223","article-title":"Luteal phase support in normoovulatory women stimulated with clomiphene citrate for intrauterine insemination: Need or habit?","volume":"25","author":"Kyrou","year":"2010","journal-title":"Hum Reprod"},{"key":"R29-8-20240905","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.fertnstert.2013.06.034","article-title":"Progesterone luteal support after ovulation induction and intrauterine insemination: A systematic review and meta-analysis","volume":"100","author":"Hill","year":"2013","journal-title":"Fertil Steril"},{"key":"R30-8-20240905","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.fertnstert.2017.01.011","article-title":"Progesterone luteal support after ovulation induction and intrauterine insemination: An updated systematic review and meta-analysis","volume":"107","author":"Green","year":"2017","journal-title":"Fertil Steril"},{"key":"R31-8-20240905","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10815-013-0127-6","article-title":"Efficacy of luteal phase support with vaginal progesterone in intrauterine insemination: A systematic review and meta-analysis","volume":"31","author":"Miralpeix","year":"2014","journal-title":"J Assist Reprod Genet"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.JHRS_100_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:35:24Z","timestamp":1786736124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.JHRS_100_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_100_20","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}